{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA L30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The pathological hallmark of Parkinson’s disease is the deposition of intracytoplasmic neuronal inclusions termed Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated if the A30P mutation not only modulates the kinetics of aS aggregation, but also alters the structure of amyloid fibrils.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant (NMR spectroscopy) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "We optimized the method of quenched hydrogen/deuterium exchange coupled to NMR spectroscopy and performed two-dimensional proton-detected high-resolution magic angle spinning experiments.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type aS) and replicates were used for the experiments, and the specific instance of the assay has been previously validated in other studies."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The combined data indicate that the A30P mutation does not cause changes in the number, location and overall arrangement of b-strands in amyloid fibrils of aS.",
          "judgment": "No PS3/BS3",
          "reasoning": "The statistical analyses in the paper are insufficient to estimate or calculate OddsPath for the functional data for this variant."
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": ""
      },
      "overall_conclusion": "Due to insufficient statistical analysis, we cannot assign a strength rating to the functional evidence for this variant."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "L",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA L46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The pathological hallmark of Parkinson’s disease is the deposition of intracytoplasmic neuronal inclusions termed Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated if the A30P mutation not only modulates the kinetics of aS aggregation, but also alters the structure of amyloid fibrils.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant (NMR spectroscopy) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "We optimized the method of quenched hydrogen/deuterium exchange coupled to NMR spectroscopy and performed two-dimensional proton-detected high-resolution magic angle spinning experiments.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type aS) and replicates were used for the experiments, and the specific instance of the assay has been previously validated in other studies."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The combined data indicate that the A30P mutation does not cause changes in the number, location and overall arrangement of b-strands in amyloid fibrils of aS.",
          "judgment": "No PS3/BS3",
          "reasoning": "The statistical analyses in the paper are insufficient to estimate or calculate OddsPath for the functional data for this variant."
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": ""
      },
      "overall_conclusion": "Due to insufficient statistical analysis, we cannot assign a strength rating to the functional evidence for this variant."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "53"
        },
        "variant_string_id": "SNCA L53P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The pathological hallmark of Parkinson’s disease is the deposition of intracytoplasmic neuronal inclusions termed Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We investigated if the A30P mutation not only modulates the kinetics of aS aggregation, but also alters the structure of amyloid fibrils.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant (NMR spectroscopy) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "We optimized the method of quenched hydrogen/deuterium exchange coupled to NMR spectroscopy and performed two-dimensional proton-detected high-resolution magic angle spinning experiments.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type aS) and replicates were used for the experiments, and the specific instance of the assay has been previously validated in other studies."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The combined data indicate that the A30P mutation does not cause changes in the number, location and overall arrangement of b-strands in amyloid fibrils of aS.",
          "judgment": "No PS3/BS3",
          "reasoning": "The statistical analyses in the paper are insufficient to estimate or calculate OddsPath for the functional data for this variant."
        }
      ],
      "final_evidence_strength": {
        "type": "N/A",
        "strength": ""
      },
      "overall_conclusion": "Due to insufficient statistical analysis, we cannot assign a strength rating to the functional evidence for this variant."
    }
  ]
}